Suppr超能文献

肾脏捐献者的长期风险。

Long-term risks for kidney donors.

机构信息

Department of Transplant Medicine, Oslo University Hospital, Oslo, Norway.

1] Department of Nephrology, St Olav University Hospital, Trondheim, Norway [2] Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

出版信息

Kidney Int. 2014 Jul;86(1):162-7. doi: 10.1038/ki.2013.460. Epub 2013 Nov 27.

Abstract

Previous studies have suggested that living kidney donors maintain long-term renal function and experience no increase in cardiovascular or all-cause mortality. However, most analyses have included control groups less healthy than the living donor population and have had relatively short follow-up periods. Here we compared long-term renal function and cardiovascular and all-cause mortality in living kidney donors compared with a control group of individuals who would have been eligible for donation. All-cause mortality, cardiovascular mortality, and end-stage renal disease (ESRD) was identified in 1901 individuals who donated a kidney during 1963 through 2007 with a median follow-up of 15.1 years. A control group of 32,621 potentially eligible kidney donors was selected, with a median follow-up of 24.9 years. Hazard ratio for all-cause death was significantly increased to 1.30 (95% confidence interval 1.11-1.52) for donors compared with controls. There was a significant corresponding increase in cardiovascular death to 1.40 (1.03-1.91), while the risk of ESRD was greatly and significantly increased to 11.38 (4.37-29.6). The overall incidence of ESRD among donors was 302 cases per million and might have been influenced by hereditary factors. Immunological renal disease was the cause of ESRD in the donors. Thus, kidney donors are at increased long-term risk for ESRD, cardiovascular, and all-cause mortality compared with a control group of non-donors who would have been eligible for donation.

摘要

先前的研究表明,活体肾脏捐献者能够长期维持肾功能,且心血管疾病或全因死亡率不会增加。然而,大多数分析纳入的对照组患者的健康状况不如活体供者人群,随访时间相对较短。在此,我们比较了长期肾功能以及心血管疾病和全因死亡率在活体肾脏捐献者与适合捐献的对照组个体之间的差异。在 1901 名于 1963 年至 2007 年期间捐献肾脏的个体中,发现了全因死亡率、心血管死亡率和终末期肾病(ESRD),中位随访时间为 15.1 年。选择了 32621 名潜在适合的肾脏捐献者作为对照组,中位随访时间为 24.9 年。与对照组相比,供者的全因死亡风险比显著升高(危险比为 1.30,95%置信区间为 1.11-1.52)。心血管死亡的相应风险显著增加(危险比为 1.40,1.03-1.91),而 ESRD 的风险则大大且显著增加(危险比为 11.38,4.37-29.6)。供者的 ESRD 总体发生率为 302 例/百万人,可能受到遗传因素的影响。免疫性肾脏疾病是供者 ESRD 的原因。因此,与适合捐献但未捐献的对照组个体相比,肾脏捐献者长期患有 ESRD、心血管疾病和全因死亡率的风险增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验